The results showed that SG significantly inhibited cell growth in Trop‐2‐expressing cancer cells (DU‐145), while Trop‐2 negative PC‐3 cells exhibited resistance to SG treatment (p < 0.001) (Figure 2C). This evidence concerns the gene TACSTD2 and cancer.